TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260409. A total of 26 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $119,000 | -88.0% | 202,062 | -9.1% | 0.00% | – |
| Q2 2018 | $989,000 | +69.3% | 222,253 | +11.9% | 0.00% | – |
| Q1 2018 | $584,000 | -0.2% | 198,537 | +17.2% | 0.00% | – |
| Q4 2017 | $585,000 | -19.5% | 169,446 | +6.3% | 0.00% | – |
| Q3 2017 | $727,000 | -9.0% | 159,393 | -13.6% | 0.00% | – |
| Q2 2017 | $799,000 | +19.6% | 184,377 | +28.8% | 0.00% | – |
| Q1 2017 | $668,000 | – | 143,113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|